Another possible factor for the lower incidence of MIS-C in younger children could be the lower expression of the cell surface enzyme angiotensin-converting enzyme 2 (ACE2) [43]. Here, ACE2 is linked to COVID-19–associated multisystem inflammatory syndrome in children.